AIP.NASDAQArteris, INC

Form 4: Arteris Director Joachim Kunkel Acquires Shares as Deferred Compensation

Sentiment:

Insider Transaction Report


Arteris, Inc. Director Joachim Kunkel acquired 1,727 shares of common stock as fully vested restricted stock, representing deferred retainer fees.

Delay expectedThe reporting person elected to defer the receipt of the 1,727 shares of common stock.

Summary

  • Joachim Kunkel, a Director of Arteris, Inc. (AIP), acquired 1,727 shares of common stock.
  • The acquisition is scheduled for July 5, 2025, and represents fully vested restricted stock.
  • These shares are retainer fees that Kunkel elected to receive in stock instead of cash.
  • Kunkel elected to defer the receipt of these shares.
  • Following this transaction, Kunkel will beneficially own 66,322 shares of Arteris, Inc. common stock directly.

Sentiment

Score: 6

Explanation: The transaction is a routine insider compensation event, indicating alignment of director's interests with shareholders, with no significant positive or negative implications for company operations or financial health.

Positives

  • Director Joachim Kunkel elected to receive retainer fees in common stock, aligning his interests with shareholders.
  • The shares are fully vested, indicating immediate ownership rights upon receipt.

Future Outlook

The document does not provide forward-looking statements regarding the company's financial performance or strategic direction, focusing solely on an insider's stock acquisition.

Industry Context

This Form 4 filing details a routine insider compensation event, which is common across publicly traded companies and does not reflect broader industry trends or competitive dynamics.

Related Party Transactions

  • Director Joachim Kunkel received 1,727 shares of common stock as fully vested restricted stock, representing retainer fees, which is a transaction between a related party (director) and the company as part of standard compensation practices.

Stakeholder Impact

  • Shareholders: The transaction aligns the director's financial interests more closely with those of the shareholders through stock-based compensation.

Next Steps

  • The actual receipt of 1,727 shares of common stock by Joachim Kunkel on July 5, 2025.

Key Dates

DateDescription
07/05/2025Date of acquisition of 1,727 shares of common stock by Joachim Kunkel, representing deferred retainer fees.
07/08/2025Date the Form 4 was signed by Paul Alpern as Attorney-in-Fact for Joachim Kunkel.

Keywords

Arteris, AIP, Form 4, insider transaction, stock compensation, director, beneficial ownership, restricted stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.